Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

March 16, 2023

Eng stresses need for clinical trial support at cancer forum

Vanderbilt’s Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
March 9, 2023

Osterman named Associate Vice President for Research Informatics

Travis Osterman, DO, MS, has been appointed to a new role as Associate Vice President for Research Informatics at Vanderbilt University Medical Center.

By Mia Garchitorena-Scancarelli
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.

By Tom Wilemon
March 2, 2023

Eng invited to White House Cancer Moonshot forum

Vanderbilt’s Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.

By Leigh MacMillan
February 16, 2023

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

By Kelsey Pinckard
February 16, 2023

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.
By Tom Wilemon
February 16, 2023

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt's Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.
By Tom Wilemon
February 9, 2023

Patient designs shoes for Coaches vs. Cancer game

Vanderbilt patient Jayden Bailey designed a special pair of Nike Air Max shoes for Jerry Stackhouse, coach of the Vanderbilt University men’s basketball team, to wear during the Jan. 24 Coaches vs. Cancer “Suits and Sneakers” basketball game.
By Christina Echegaray
February 9, 2023

‘Biopsy Queen’ reaches milestone number of procedures

Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.
By Tom Wilemon
February 9, 2023

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.
By Craig Boerner
February 9, 2023

Vanderbilt-Ingram joins CancerLinQ quality initiative

Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
By Tom Wilemon
February 6, 2023

Berlin named director of Division of Hematology and Oncology

Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
By Tom Wilemon
1 … 9 10 11 12 13 … 28